N-n axial chiral phase transfer catalyst, synthesis method and application

The five-step reaction method for synthesizing NN-axis chiral phase transfer catalysts with a bicarbazole cyclic ether framework solves the problems of complex synthesis, high cost, and poor substrate-phase transfer performance in existing technologies, and realizes efficient and low-cost catalyst preparation and industrial application.

CN122356069APending Publication Date: 2026-07-10HENAN UNIV OF CHINESE MEDICINE
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202610566139.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-04-27
Publication Date
2026-07-10

AI Technical Summary

Technical Problem

Existing NN-axis chiral quaternary ammonium salt phase transfer catalysts have cumbersome synthesis steps, high costs, poor substrate and phase transfer performance, making it difficult to achieve large-scale industrial production. Furthermore, they lack sufficient catalytic activity and stereoselectivity for complex multifunctional substrates.

Method used

A five-step reaction involving Mitsunobu reaction, deprotection, oxidative cyclization, radical bromomethylation, and intramolecular quaternization was employed. Using 1,1'-bicarbazole as the core, an NN-axis chiral bicarbazole cyclic ether skeleton was synthesized via chiral 2,4-pentanediol and N-Boc-indophenol, thus constructing an NN-axis chiral phase transfer catalyst with a high ee value.

Benefits of technology

It achieves high yield and high stereoselectivity of catalyst preparation, improves catalytic activity and stereoselectivity, enhances phase transfer efficiency and substrate universality, is suitable for industrial production, and also has biological activity.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN122356069A_ABST
    Figure CN122356069A_ABST
Patent Text Reader

Abstract

This invention discloses an N-N axial chiral phase-transfer catalyst, its synthesis method, and its applications, belonging to the field of asymmetric catalytic synthesis technology. Using chiral 2,4-pentanediol and N-Boc-indolephenol as starting materials, this invention efficiently constructs an N-N axial chiral biscarbazole cyclic ether skeleton through a five-step reaction involving Mitsunobu etherification, deBoc protection, PIDA oxidative cyclization, radical bromoxymethylation, and intramolecular quaternization. This method eliminates the need for complex chiral resolution and noble metal coupling, employs mild reaction conditions, uses readily available and inexpensive starting materials, achieves high overall yield, and yields a product with an axial chirality ee value ≥98%. The resulting catalyst possesses excellent conformational rigidity, chiral induction ability, and phase-transfer performance, exhibiting broad substrate applicability. It also possesses bisindole ring bioactivity, making it widely applicable in asymmetric catalytic synthesis in pharmaceuticals, fine chemicals, and other fields, and providing new directions for the development of antibacterial and antitumor biomaterials.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of asymmetric catalytic synthesis technology, and more specifically to an N-axis chiral phase transfer catalyst, its synthesis method, and its application. Background Technology

[0002] Phase transfer catalysis is a highly efficient core strategy in organic synthesis for achieving asymmetric transformations at the organic or aqueous phase interface. With its significant advantages such as mild reaction conditions, no need for strictly anhydrous and oxygen-free operation, simple reaction system, and suitability for industrial-scale production, it is widely used in asymmetric synthesis processes in pharmaceuticals, pesticides, and fine chemicals. Chiral quaternary ammonium salts are the most classic and widely used type of phase transfer catalyst. The core determinant of their catalytic activity and stereoselectivity is the chiral environment design of the core framework. The conformational rigidity, steric hindrance effect, and hydrophilic / hydrophobic properties of the chiral framework directly affect the binding efficiency between the catalyst and the reactant, the stability of the reaction transition state, and thus determine the yield and enantioselectivity of asymmetric catalysis.

[0003] NN-axis chiral frameworks, due to their unique conformational rigidity and steric hindrance, have chiral centers that are not easily racemized, providing a stable and controllable chiral microenvironment for asymmetric catalytic reactions. They exhibit excellent chiral induction potential in the field of asymmetric catalysis, making them an important research direction for the design of chiral phase transfer catalyst frameworks. However, existing NN-axis chiral quaternary ammonium salt phase transfer catalysts still face several unresolved technical problems: First, the synthesis steps are cumbersome, with most catalysts requiring complex reactions such as multi-step chiral resolution and noble metal catalytic coupling, making the construction of chiral centers difficult and imposing stringent requirements on reaction equipment and operating processes. Second, the raw material costs are high, with some synthetic routes relying on rare chiral raw materials or expensive catalysts, making large-scale industrial production difficult. Third, the substrate universality is limited; existing catalysts only show good catalytic effects for a few simple asymmetric reactions, and their catalytic activity and stereoselectivity significantly decrease for asymmetric transformations of complex multifunctional substrates. Fourth, the hydrophilic / hydrophobic properties of some catalysts are poorly designed, resulting in poor solubility in water-organic two-phase phase transfer catalytic systems, low phase transfer efficiency, and further reduced catalytic effects.

[0004] Bisindole quaternary ammonium salt compounds possess both the bioactivity of indole rings and the phase-transfer catalytic properties of quaternary ammonium salts. Combining the N-N axis chiral framework with the bisindole quaternary ammonium salt structure holds promise for developing novel compounds exhibiting both excellent chiral catalytic performance and bioactivity. However, research on N-N axis chiral bisindole quaternary ammonium salt phase-transfer catalysts is scarce, and existing methods for synthesizing bisindole quaternary ammonium salt compounds suffer from problems such as long process routes, harsh reaction conditions, low product yields, and difficulty in controlling chirality, failing to meet the needs of industrial production and practical applications.

[0005] Therefore, it is necessary to develop a novel, simple to prepare, inexpensive and readily available raw materials, and mild reaction conditions for an N-axis chiral phase transfer catalyst and its synthesis method. This would enable the catalyst to be prepared with high yield and high stereoselectivity, while improving the substrate universality, phase transfer efficiency and bioactivity of the catalyst. This would have significant academic research value and industrial application prospects, and could also provide new ideas and directions for the development of antibacterial and antitumor biomedical materials. Summary of the Invention

[0006] The purpose of this invention is to solve the problems of complex synthesis, high cost, poor substrate-phase transfer performance, and difficulty in efficiently preparing NN-axis chiral quaternary ammonium salt phase transfer catalysts.

[0007] To achieve the above objectives, the present invention specifically adopts the following technical solution:

[0008] An N-N axis chiral phase transfer catalyst has the following general chemical structural formula:

[0009] , wherein R is selected from C1-C18 alkyl, C3-C8 cycloalkyl, aryl or aralkyl.

[0010] Furthermore, the chemical structure uses 1,1'-bicarbazole as the core, and forms a rigid ring structure by bridging quaternized nitrogen atoms with methylene groups, which has the characteristic of connecting the biscarbazole skeleton and the quaternary ammonium salt cation with NN bonds.

[0011] Furthermore, the catalyst axial chirality ee value is ≥98%.

[0012] A method for synthesizing an N-axis chiral phase transfer catalyst, using chiral 2,4-pentanediol and N-Boc-indophenol as starting materials, involves sequentially proceeding through Mitsunobu reaction etherification, deprotection of the Boc group, intramolecular oxidative cyclization to construct N-axis chirality, bridging carbon functionalization and radical bromomethylation, and intramolecular quaternization reactions. The specific steps include:

[0013] The S1 and Mitsunobu reaction achieves dihydroxy etherification to give bis(indophenol)pentane derivatives;

[0014] S2. Remove the Boc protecting group on N to obtain a free bis(indophenol)pentane derivative;

[0015] S3, intramolecular oxidative cyclization, to construct a bicarbazole cyclic ether skeleton with NN axis chirality;

[0016] S4, functionalization of the bridging carbon and radical bromomethylation, yield a dibromomethyl-substituted biscarbazole intermediate;

[0017] S5, intramolecular quaternization reaction, yields the target NN-axis chiral phase transfer catalyst.

[0018] Further, the specific operation and process parameters of S1 are as follows: using chiral 2,4-pentanediol and N-Boc-indophenol as raw materials, in the presence of DIAD and PPh3, and with anhydrous THF as solvent, a Mitsunobu reaction is carried out at 0℃-room temperature; wherein the molar ratio of chiral 2,4-pentanediol, N-Boc-indophenol, DIAD, and PPh3 is 1:(2-2.5):(2-2.8):(2-2.8), the reaction time is 12-16h, and after the reaction is completed, the bis(indophenol)pentane derivative is obtained by vacuum concentration and silica gel column chromatography purification.

[0019] Further, the specific operation and process parameters of S2 are as follows: the bis(indophenol)pentane derivative obtained in S1 is refluxed with K2CO3 in a mixed solvent of methanol and water; wherein the molar ratio of bis(indophenol)pentane derivative to K2CO3 is 1:(3.5-4.5), the volume ratio of methanol to water is 4:1, the reflux reaction time is 6-8h, and after the reaction is completed, the free bis(indophenol)pentane derivative is obtained by vacuum concentration, extraction, drying and concentration.

[0020] Furthermore, the specific operation and process parameters of S3 are as follows: using PIDA as an oxidant, the free bis(indophenol)pentane derivative obtained in S2 is subjected to an intramolecular oxidative cyclization reaction in dichloromethane solvent;

[0021] The molar ratio of bis(indophenol)pentane derivative to PIDA was 1:(1.7-2.3). The reaction was stirred at room temperature for 8-12 hours. After the reaction was completed, the oxidant was quenched, the mixture was separated, washed, dried and concentrated, and purified by silica gel column chromatography to obtain a biscarbazole cyclic ether skeleton with N-N axis chirality.

[0022] Further, the specific operation and process parameters of S4 are as follows: Under an argon protective atmosphere, using the NN-axis chiral biscarbazole cyclic ether skeleton obtained in S3 as the reaction substrate, 20 mol% of NiBr2·glyme and 40 mol% of PCy3 of the substrate are added. Anhydrous 1,4-dioxane is used as the solvent and stirred for 30 minutes. Then, the system is cooled to -78°C and 4 equivalents of MeMgBr of the reaction substrate are added dropwise. After the dropwise addition is completed, the mixture is stirred at room temperature for 4 to 6 hours to complete the functionalization reaction of the bridged carbon. Subsequently, 10 mol% of AIBN and 2.1 equivalents of NBS of the reaction substrate are added to the reaction system. The mixture is heated to 60°C to initiate a free radical reaction and kept at this temperature for 2 to 3 hours. After the reaction is completed, the mixture is quenched, extracted, dried and concentrated, and purified by silica gel column chromatography to finally obtain the dibromomethyl-substituted biscarbazole intermediate.

[0023] Further, the specific operation and process parameters of S5 are as follows: the dibromomethyl-substituted biscarbazole intermediate obtained in S4 is mixed with the secondary amine NHRCH3 in acetonitrile solvent, and an intramolecular quaternization reaction is carried out at 50-100℃; wherein the molar ratio of the dibromomethyl-substituted biscarbazole intermediate to the secondary amine is 1:(1.2-1.8), the reaction time is 12-16h, and after the reaction is completed, the target NN axis chiral phase transfer catalyst is obtained by vacuum concentration, washing, recrystallization, and column chromatography purification.

[0024] The secondary amine is N-benzylmethylamine, N-cyclohexylmethylamine, N-isobutylmethylamine, or N-n-octylmethylamine.

[0025] An application of an NN-axis chiral phase transfer catalyst, which can be used in the preparation of antibacterial drugs, antitumor lead drugs, and bioimaging probes, and can also be used as a phase transfer catalyst in asymmetric organic synthesis reactions.

[0026] Compared with the prior art, the beneficial effects of the present invention are as follows:

[0027] 1. This invention employs a five-step reaction process: Mitsunobu etherification, deprotection, oxidative cyclization, radical bromoxymethylation, and intramolecular quaternization. It does not require precious metal coupling or complex chiral resolution, uses inexpensive and readily available raw materials, has mild reaction conditions, and achieves high overall yield, making it suitable for industrial scale-up.

[0028] 2. This invention constructs an NN-axis chiral bicarbazole cyclic ether skeleton with strong conformational rigidity and stable chiral center, resulting in a product ee value ≥98%. This provides efficient chiral induction and enhances the activity and stereoselectivity of asymmetric catalysis.

[0029] 3. This invention combines NN axis chirality with bisindole quaternary ammonium salt, possessing both excellent phase transfer catalytic performance and potential biological activity. It has stronger substrate universality and higher phase transfer efficiency, and can be used for asymmetric synthesis and the development of antibacterial and antitumor biomedical materials. Attached Figure Description

[0030] Figure 1 This is the synthetic route for the NN-axis chiral phase transfer catalyst of this invention. Detailed Implementation

[0031] The technical solutions of the present invention will be clearly and completely described below with reference to the embodiments of the present invention. Obviously, the described embodiments are only some embodiments of the present invention, and not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art without creative effort are within the scope of protection of the present invention.

[0032] Please see Figure 1 This invention uses chiral 2,4-pentanediol and N-Boc-indophenol as starting materials to synthesize an N-N axis chiral phase transfer catalyst. The specific steps are as follows:

[0033] Step 1: Using chiral 2,4-pentanediol and N-Boc-indophenol as raw materials, a Mitsunobu reaction is carried out in the presence of diisopropyl azodicarbonate and triphenylphosphine, with anhydrous THF as solvent, at 0℃-room temperature. The molar ratio of chiral 2,4-pentanediol, N-Boc-indophenol, and DIAD,PPh3 is 1:(2-2.5):(2-2.8):(2-2.8). The reaction time is 12-16 h to achieve the etherification of the dihydroxyl group, yielding a bis(indophenol)pentane derivative.

[0034] Step 2: The bis(indophenol)pentane derivative was reacted with K2CO3 under reflux in a mixed solvent of methanol and water. The molar ratio of bis(indophenol)pentane derivative to K2CO3 was 1:(3.5-4.5); the volume ratio of methanol to water was 4:1; and the reflux time was 6-8 h. The Boc protecting group on N was removed to obtain the free bis(indophenol)pentane derivative.

[0035] Step 3: Using diacetic iodobenzene as an oxidant, the bis(indophenol)pentane derivative was subjected to intramolecular oxidative cyclization. The molar ratio of the bis(indophenol)pentane derivative to PIDA was 1:1.7-2.3. Dichloromethane was used as a solvent. The mixture was stirred at room temperature for 8-12 hours to construct a biscarbazole cyclic ether skeleton with N-N axis chirality.

[0036] Step 4: Under argon protection, using the N-N axis-chiral biscarbazole cyclic ether skeleton obtained in Step 3 as the reaction substrate and anhydrous 1,4-dioxane as the solvent, 20 mol% NiBr2·glyme and 40 mol% tricyclohexylphosphine were added. After stirring for 30 min, 4 equivalents of the reaction substrate methyl magnesium bromide were added dropwise at -78 °C. After the addition was completed, the mixture was stirred continuously at room temperature for 4 to 6 hours to complete the functionalization reaction of the bridged carbon. 10 mol% azobisisobutyronitrile and 2.1 equivalents of the reaction substrate N-bromosuccinimide were added to the above system, and the mixture was heated to 60 °C to initiate a free radical reaction. The reaction was carried out for 2 to 3 h to obtain the biscarbazole intermediate with dibromomethyl substitution.

[0037] Step 5: The dibromomethyl-substituted biscarbazole intermediate and the corresponding secondary amine NHRCH3 are reacted in acetonitrile or DMF solvent, with the molar ratio of the dibromomethyl-substituted biscarbazole intermediate to the secondary amine being 1:(1.2-1.8); the mixture is heated under reflux for 12-16 h at 50 to 100 °C to undergo an intramolecular quaternization reaction, yielding an NN-axis chiral phase transfer catalyst.

[0038] Example 1:

[0039] Using N-benzylmethylamine as a secondary amine, the N-N axis chiral phase transfer catalyst C1 was synthesized.

[0040] Step 1: The Mitsunobu reaction is used to achieve dihydroxy etherification, preparing bis(indophenol)pentane derivatives;

[0041] Feed amounts: Based on 1.0 mmol of chiral 2,4-pentanediol: 0.104 g of chiral 2,4-pentanediol with a purity ≥98% and an ee value ≥99%, 0.483 g of 2.2 mmol of N-Boc-indophenol, 0.566 g of 2.8 mmol of DIAD, 0.734 g of 2.8 mmol of PPh3, and 10 mL of anhydrous THF as solvent.

[0042] Procedure: In a dry reaction flask, chiral 2,4-pentanediol, N-Boc-indophenol, and anhydrous THF were added sequentially under an ice-water bath at 0°C, and the mixture was magnetically stirred until completely dissolved. PPh3 was added slowly in portions, and the temperature was further lowered to 0°C after the addition was complete. DIAD was dissolved in 5 mL of anhydrous THF and slowly added dropwise to the reaction system through a constant-pressure dropping funnel over a period of 30 min. After the addition was complete, the ice-water bath was removed, and the mixture was allowed to rise naturally to room temperature. The reaction was continued with stirring for 14 h, with the developing solvent ratio monitored by TLC: petroleum ether: ethyl acetate = 5:1, until the starting material spot disappeared. After the reaction was complete, the solvent was concentrated under reduced pressure to remove most of the solvent. The residue was purified by silica gel column chromatography with the eluent: petroleum ether: ethyl acetate = 8:1, yielding 0.382 g of a white solid bis(indophenol)pentane derivative, with a yield of 75%.

[0043] Step 2: Remove the Boc protecting group to prepare free bis(indophenol)pentane derivative;

[0044] Feed amounts: 0.382 g of 0.75 mmol bis(indophenol)pentane derivative obtained in step 1, 0.456 g of 3.375 mmol K2CO3, and 10 mL of a mixed solvent of methanol:water = 4:1.

[0045] Procedure: The bis(indophenol)pentane derivative and K2CO3 were added to a reaction flask, followed by a prepared methanol-water mixture. After stirring thoroughly, the mixture was heated to reflux and maintained at reflux for 7 hours. The ratio of the developing solvent was monitored by TLC as petroleum ether:ethyl acetate = 3:1 until the Boc-substituted starting material spot disappeared. After the reaction was completed, the methanol was removed by concentration under reduced pressure. 5 mL of deionized water was added to the residue, and the mixture was extracted three times with 10 mL of dichloromethane. The organic phases were combined and dried overnight with anhydrous Na2SO4. After filtration, the mixture was concentrated under reduced pressure to obtain 0.265 g of a pale yellow solid free bis(indophenol)pentane derivative, with a yield of 92%.

[0046] Step 3: PIDA oxidation cyclization to construct an NN-axis chiral bicarbazole cyclic ether skeleton;

[0047] Feeding amounts: 0.265 g of 0.69 mmol free bis(indophenol)pentane derivative, 0.468 g of 1.49 mmol PIDA obtained in step 2, and 15 mL of dichloromethane as solvent.

[0048] Procedure: The free bis(indophenol)pentane derivative was added to a dry reaction flask, and dichloromethane was added and stirred to dissolve it. PIDA was slowly added in portions at room temperature. The ratio of petroleum ether to ethyl acetate was monitored by TLC: 6:1. After the addition was complete, the reaction was continued to be magnetically stirred at room temperature for 10 h until the starting spot disappeared. After the reaction was completed, 5 mL of saturated Na2S2O3 solution was added to the system, and the mixture was stirred for 10 min to quench excess oxidant. The mixture was allowed to stand and separated. The organic phase was washed twice with 10 mL of saturated NaCl solution, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography with the eluent being petroleum ether to ethyl acetate in a ratio of 6:1, yielding 0.213 g of a white solid NN-axis chiral biscarbazole cyclic ether skeleton, with a yield of 82%. The axial chirality ee value was ≥98% as determined by HPLC.

[0049] Step 4: Bridged carbon functionalization and radical bromomethylation to prepare a dibromomethyl-substituted biscarbazole intermediate;

[0050] Feeding amounts: Based on a 0.5 mmol bicarbazole cyclic ether skeleton, 0.168 g of the NN-axis chiral bicarbazole cyclic ether skeleton obtained in step 3, 0.029 g of 20 mol% NiBr2·glyme, 0.056 g of 40 mol% PCy3, 2 mL of 4.0 mmol 1M MeMgBr diethyl ether solution, 0.008 g of 10 mol% AIBN, 0.187 g of 1.05 mmol NBS, and 10 mL of anhydrous 1,4-dioxane were used as solvents.

[0051] Procedure: Under an argon atmosphere, add the biscarbazole cyclic ether skeleton, NiBr2·glyme, PCy3, and anhydrous 1,4-dioxane sequentially to a dry Shrek flask. Stir magnetically at room temperature for 30 min to allow the catalyst to fully complex. Place the reaction flask in a -78°C dry ice-acetone bath and slowly add MeMgBr diethyl ether solution dropwise through a constant pressure dropping funnel. After the addition is complete, maintain the reaction temperature at -78°C for 1 h, then continue stirring for 5 h before raising the temperature to room temperature. Monitor the developing solvent ratio by TLC: petroleum ether: ethyl acetate = 10:1 until the methylation precursor spots disappear. Add AIBN and NBS directly to the above methylation reaction system, place the reaction flask in a 60°C oil bath, and heat and stir to initiate the free radical reaction. React for 2.5 h until the bromomethylation precursor spots disappear. After the reaction was completed, the reaction flask was placed in an ice-water bath, and 5 mL of ice water was added to quench the reaction. After standing, it was extracted three times with 10 mL of dichloromethane. The organic phases were combined, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography with petroleum ether:ethyl acetate = 10:1 as the eluent to give 0.189 g of a pale yellow solid dibromomethyl-substituted biscarbazole intermediate, with a yield of 85%.

[0052] Step 5: Intramolecular quaternization to prepare the target catalyst C1;

[0053] Feed amounts: 0.189 g of the 0.425 mmol dibromomethyl-substituted bicarbazole intermediate obtained in step 4, 0.061 g of 0.51 mmol N-benzylmethylamine, and 10 mL of acetonitrile as solvent.

[0054] Procedure: The dibromomethyl-substituted biscarbazole intermediate and N-benzylmethylamine were added to a reaction flask, acetonitrile was added and stirred to dissolve, and the mixture was heated to 80°C and refluxed. The reaction was maintained at this temperature for 14 h. The ratio of the developing solvent was monitored by TLC: dichloromethane:methanol = 10:1 until the intermediate spot disappeared. After the reaction was completed, the acetonitrile was removed by concentration under reduced pressure. The residue was washed three times with 5 mL of anhydrous diethyl ether, filtered, and the solid was placed in a vacuum drying oven and dried at 40°C for 4 h to obtain 0.198 g of white solid N-axis chiral phase transfer catalyst C1, with a yield of 88%.

[0055] Product characteristics: 1 ¹H NMR (400 MHz, CDCl₃) δ 7.82–7.78 (m, 4H, carbazole ring aryl hydrogen), 7.45–7.30 (m, 9H, benzyl aryl hydrogen + carbazole ring aryl hydrogen), 4.85 (s, 4H, -CH₂Br derived quaternary ammonium salt -CH₂-), 4.22 (s, 2H, benzyl-CH₂-), 3.15 (s, 3H, -NCH₃), 2.98–2.85 (m, 2H, pentane-bridged -CH₃), 1.32 (d, J = 6.4 Hz, 6H, pentane-CH₃); Melting point: 187–189 °C; axial chirality ee value ≥98% as determined by HPLC.

[0056] Example 2:

[0057] Using N-cyclohexylmethylamine as a secondary amine, the N-axis chiral phase transfer catalyst C2 was synthesized. The operation, feed amount, and process parameters of steps 1-4 were completely consistent with those in Example 1, and 0.189 g (0.425 mmol) of dibromomethyl-substituted biscarbazole intermediate was obtained. Only step 5 is described in detail below.

[0058] Step 5: Intramolecular quaternization to prepare the target catalyst C2;

[0059] Feed amounts: 0.189 g of 0.425 mmol dibromomethyl-substituted biscarbazole intermediate, 0.054 g of 0.467 mmol N-cyclohexylmethylamine, and 8 mL of LDMF as solvent.

[0060] Procedure: The dibromomethyl-substituted biscarbazole intermediate and N-cyclohexylmethylamine were added to a dry reaction flask, and DMF was added and stirred until completely dissolved. The reaction flask was placed in an oil bath and heated to 90°C for 12 h. The developing solvent ratio was dichloromethane:methanol = 10:1. TLC was used to monitor the reaction until the intermediate spots disappeared. After the reaction was completed, the reaction system was cooled to room temperature and slowly poured into 20 mL of ice water. The mixture was magnetically stirred for 10 min, and a large amount of white solid precipitated. The solid was collected by vacuum filtration. When recrystallizing the solid with anhydrous ethanol, the ethanol was heated to reflux to dissolve the solid, and the crystals were slowly cooled to room temperature. After vacuum filtration, the crystals were dried to obtain 0.191 g of white crystalline N-axis chiral phase transfer catalyst C2, with a yield of 86%.

[0061] Product characteristics: 1 ¹H NMR (400 MHz, CD₃CN) δ 7.80–7.76 (m, 4H, carbazole ring aryl hydrogen), 7.40–7.32 (m, 4H, carbazole ring aryl hydrogen), 4.82 (s, 4H, quaternary ammonium salt -CH₂-), 3.85–3.78 (m, 1H, cyclohexyl-CH₂-), 3.12 (s, 3H, -NCH₃), 2.95–2.82 (m, 2H, pentane-bridged -CH₃-), 1.95–1.20 (m, 10H, cyclohexyl-CH₂-), 1.30 (d, J=6.4 Hz, 6H, pentane-CH₃); Melting point: 203–205 °C; axial chirality ee value ≥98% as determined by HPLC.

[0062] Example 3:

[0063] Using N-isobutylmethylamine as a secondary amine, the N-axis chiral phase transfer catalyst C3 was synthesized. The operation, feed amount, and process parameters of steps 1-4 were completely consistent with those in Example 1, and 0.189 g (0.425 mmol) of dibromomethyl-substituted biscarbazole intermediate was obtained. Only step 5 is described in detail below.

[0064] Step 5: Intramolecular quaternization to prepare the target catalyst C3;

[0065] Feed amounts: 0.189 g (0.425 mmol) of dibromomethyl-substituted biscarbazole intermediate, 0.043 g (0.494 mmol) of N-isobutylmethylamine, and 10 mL of acetonitrile as solvent.

[0066] Procedure: The dibromomethyl-substituted biscarbazole intermediate and N-isobutylmethylamine were added to a reaction flask, acetonitrile was added and stirred to dissolve, and the mixture was heated to 70°C and refluxed. The reaction was maintained at this temperature for 16 h. The eluent ratio was dichloromethane:methanol = 10:1. The reaction was monitored by TLC until the intermediate spot disappeared. After the reaction was completed, the acetonitrile was removed by vacuum concentration. The residue was purified by silica gel column chromatography with an eluent ratio of dichloromethane:methanol = 15:1. The target fraction was collected, concentrated under reduced pressure, and dried in a vacuum drying oven at 40°C for 6 h to obtain 0.185 g of a pale yellow oily N-axis chiral phase transfer catalyst C3, with a yield of 89%. It was a viscous liquid at room temperature. After vacuum drying, it was sealed and stored, showing good stability.

[0067] Product characteristics: 1 ¹H NMR (400MHz, CDCl₃) δ 7.79–7.75 (m, 4H, carbazole ring aryl hydrogen), 7.39–7.31 (m, 4H, carbazole ring aryl hydrogen), 4.80 (s, 4H, quaternary ammonium salt -CH₂-), 3.25–3.18 (m, 1H, isobutyl-CH₂-), 3.10 (s, 3H, -NCH₃), 2.92–2.80 (m, 2H, pentane-bridged -CH₃-), 1.95 (d, J=6.8Hz, 2H, isobutyl-CH₂-), 1.31 (d, J=6.4Hz, 6H, pentane-CH₃), 0.92 (d, J=6.8Hz, 6H, isobutyl-CH₃); axial chirality ee value ≥98% as determined by HPLC; water solubility: readily soluble in water, solubility ≥10 mg / mL.

[0068] Example 4:

[0069] Using N-n-octylmethylamine as a secondary amine, the N-N axis chiral phase transfer catalyst C4 was synthesized. The operation, feed amount, and process parameters of steps 1-4 were completely consistent with those in Example 1, and 0.189 g of a 0.425 mmol dibromomethyl-substituted biscarbazole intermediate was obtained. Only step 5 is described in detail below.

[0070] Step 5: Intramolecular quaternization to prepare the target catalyst C4;

[0071] Feed amounts: 0.189 g (0.425 mmol) of dibromomethyl-substituted biscarbazole intermediate, 0.072 g (0.499 mmol) of N-n-octylmethylamine, and 12 mL of acetonitrile as solvent.

[0072] Procedure: The dibromomethyl-substituted biscarbazole intermediate and N-n-octylmethylamine were added to a reaction flask, acetonitrile was added and stirred to dissolve, and the mixture was heated to 85°C and refluxed. The reaction was maintained at this temperature for 15 h. The developing solvent ratio was dichloromethane:methanol = 12:1. The reaction was monitored by TLC until the intermediate spots disappeared. After the reaction was completed, the mixture was concentrated under reduced pressure to remove acetonitrile. The residue was washed three times with 5 mL of petroleum ether, filtered, and dried under vacuum to obtain 0.205 g of pale yellow waxy N-axis chiral phase transfer catalyst C4, with a yield of 87%.

[0073] Product characteristics: 1 ¹H NMR (400 MHz, CDCl₃) δ 7.80–7.76 (m, 4H, carbazole ring aryl hydrogen), 7.38–7.30 (m, 4H, carbazole ring aryl hydrogen), 4.81 (s, 4H, quaternary ammonium salt -CH₂-), 3.22–3.15 (m, 2H, n-octyl-CH₂-), 3.09 (s, 3H, -NCH₃), 2.93–2.81 (m, 2H, pentane-bridged -CH₂-). 1.72–1.65 (m, 2H, n-octyl-CH2-), 1.35–1.20 (m, 10H, n-octyl-CH2-), 1.31 (d, J=6.4Hz, 6H, pentane-CH3), 0.88 (t, J=6.8Hz, 3H, n-octyl-CH3); axial chirality ee value ≥98% as determined by HPLC; hydrophilicity / hydrophobicity: slightly soluble in water, readily soluble in nonpolar organic solvents such as toluene and dichloromethane.

[0074] The above are merely preferred embodiments of the present invention and are not intended to limit the present invention. The scope of patent protection of the present invention shall be determined by the claims. Similarly, any equivalent structural changes made based on the content of the present invention's specification shall also be included within the scope of protection of the present invention.

Claims

1. An N-axis chiral phase transfer catalyst, characterized in that, Its general chemical structural formula is as follows: , wherein R is selected from C1-C18 alkyl, C3-C8 cycloalkyl, aryl or aralkyl.

2. The NN-axis chiral phase transfer catalyst according to claim 1, characterized in that: The chemical structure is based on 1,1'-bicarbazole as the core, and a rigid ring structure is formed by quaternary ammonium nitrogen atoms connected by methylene groups. It has the characteristic of connecting the bicarbazole skeleton and the quaternary ammonium salt cation with NN bonds.

3. The NN-axis chiral phase transfer catalyst according to claim 1, characterized in that: The catalyst has an axial chirality ee value ≥ 98%.

4. A method for synthesizing the N-axis chiral phase transfer catalyst according to any one of claims 1-3, characterized in that: Starting with chiral 2,4-pentanediol and N-Boc-indophenol, the product was prepared by sequentially undergoing Mitsunobu etherification, deprotection of the Boc group, intramolecular oxidative cyclization to construct NN-axial chirality, bridging carbon functionalization and radical bromomethylation, and intramolecular quaternization. The specific steps include: The S1 and Mitsunobu reaction achieves dihydroxy etherification to give bis(indophenol)pentane derivatives; S2. Remove the Boc protecting group on N to obtain a free bis(indophenol)pentane derivative; S3, intramolecular oxidative cyclization, to construct a bicarbazole cyclic ether skeleton with NN axis chirality; S4, functionalization of the bridging carbon and radical bromomethylation, yield a dibromomethyl-substituted biscarbazole intermediate; S5, intramolecular quaternization reaction, yields the target NN-axis chiral phase transfer catalyst.

5. The method for synthesizing an N-axis chiral phase transfer catalyst according to claim 4, characterized in that: The specific operation and process parameters of S1 are as follows: using chiral 2,4-pentanediol and N-Boc-indophenol as raw materials, in the presence of DIAD and PPh3, and with anhydrous THF as solvent, a Mitsunobu reaction is carried out at 0℃-room temperature; wherein the molar ratio of chiral 2,4-pentanediol, N-Boc-indophenol, DIAD, and PPh3 is 1:(2-2.5):(2-2.8):(2-2.8), the reaction time is 12-16h, and after the reaction is completed, the bis(indophenol)pentane derivative is obtained by vacuum concentration and silica gel column chromatography purification.

6. The method for synthesizing an N-axis chiral phase transfer catalyst according to claim 4, characterized in that: The specific operation and process parameters of S2 are as follows: the bis(indophenol)pentane derivative obtained in S1 is refluxed with K2CO3 in a mixed solvent of methanol and water; wherein the molar ratio of bis(indophenol)pentane derivative to K2CO3 is 1:(3.5-4.5), the volume ratio of methanol to water is 4:1, the reflux reaction time is 6-8h, and after the reaction is completed, the free bis(indophenol)pentane derivative is obtained by vacuum concentration, extraction, drying and concentration.

7. The method for synthesizing an N-axis chiral phase transfer catalyst according to claim 4, characterized in that: The specific operation and process parameters of S3 are as follows: using PIDA as an oxidant, the free bis(indophenol)pentane derivative obtained in S2 is subjected to an intramolecular oxidative cyclization reaction in dichloromethane solvent. The molar ratio of bis(indophenol)pentane derivative to PIDA was 1:(1.7-2.3). The reaction was stirred at room temperature for 8-12 hours. After the reaction was completed, the oxidant was quenched, the mixture was separated, washed, dried and concentrated, and purified by silica gel column chromatography to obtain a biscarbazole cyclic ether skeleton with N-N axis chirality.

8. The method for synthesizing an N-axis chiral phase transfer catalyst according to claim 4, characterized in that: The specific operation and process parameters of S4 are as follows: Under an argon protective atmosphere, using the NN-axis chiral biscarbazole cyclic ether skeleton obtained in S3 as the reaction substrate, 20 mol% NiBr2·glyme and 40 mol% PCy3 of the substrate are added. Anhydrous 1,4-dioxane is used as the solvent and stirred for 30 minutes. Then, the system is cooled to -78°C and 4 equivalents of the reaction substrate MeMgBr are added dropwise. After the addition is completed, the mixture is stirred at room temperature for 4 to 6 hours to complete the functionalization reaction of the bridged carbon. Subsequently, 10 mol% AIBN and 2.1 equivalents of the reaction substrate NBS are added to the reaction system. The mixture is heated to 60°C to initiate a free radical reaction and kept at this temperature for 2 to 3 hours. After the reaction is completed, the mixture is quenched, extracted, dried and concentrated, and purified by silica gel column chromatography to finally obtain the dibromomethyl-substituted biscarbazole intermediate.

9. The method for synthesizing an N-axis chiral phase transfer catalyst according to claim 4, characterized in that: The specific operation and process parameters of S5 are as follows: the dibromomethyl-substituted biscarbazole intermediate obtained in S4 is mixed with the secondary amine NHRCH3 in acetonitrile solvent, and an intramolecular quaternization reaction is carried out at 50-100℃; wherein the molar ratio of the dibromomethyl-substituted biscarbazole intermediate to the secondary amine is 1:(1.2-1.8), the reaction time is 12-16h, and after the reaction is completed, the target NN axis chiral phase transfer catalyst is obtained by vacuum concentration, washing, recrystallization, and column chromatography purification. The secondary amine is N-benzylmethylamine, N-cyclohexylmethylamine, N-isobutylmethylamine, or N-n-octylmethylamine.

10. The application of the NN-axis chiral phase transfer catalyst according to any one of claims 1-3 in the preparation of antibacterial drugs, antitumor lead drugs, and bioimaging probes, wherein the NN-axis chiral phase transfer catalyst can also be used as a phase transfer catalyst in asymmetric organic synthesis reactions.